1. Home
  2. TNON vs GNPX Comparison

TNON vs GNPX Comparison

Compare TNON & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNON
  • GNPX
  • Stock Information
  • Founded
  • TNON 2012
  • GNPX 2009
  • Country
  • TNON United States
  • GNPX United States
  • Employees
  • TNON N/A
  • GNPX N/A
  • Industry
  • TNON Medical Specialities
  • GNPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • TNON Health Care
  • GNPX Health Care
  • Exchange
  • TNON Nasdaq
  • GNPX Nasdaq
  • Market Cap
  • TNON 11.5M
  • GNPX 10.8M
  • IPO Year
  • TNON 2022
  • GNPX 2018
  • Fundamental
  • Price
  • TNON $1.24
  • GNPX $9.61
  • Analyst Decision
  • TNON Strong Buy
  • GNPX
  • Analyst Count
  • TNON 2
  • GNPX 0
  • Target Price
  • TNON $5.50
  • GNPX N/A
  • AVG Volume (30 Days)
  • TNON 1.0M
  • GNPX 1.5M
  • Earning Date
  • TNON 11-12-2025
  • GNPX 11-12-2025
  • Dividend Yield
  • TNON N/A
  • GNPX N/A
  • EPS Growth
  • TNON N/A
  • GNPX N/A
  • EPS
  • TNON N/A
  • GNPX N/A
  • Revenue
  • TNON $2,947,000.00
  • GNPX N/A
  • Revenue This Year
  • TNON $43.52
  • GNPX N/A
  • Revenue Next Year
  • TNON $82.14
  • GNPX N/A
  • P/E Ratio
  • TNON N/A
  • GNPX N/A
  • Revenue Growth
  • TNON N/A
  • GNPX N/A
  • 52 Week Low
  • TNON $0.85
  • GNPX $7.00
  • 52 Week High
  • TNON $5.85
  • GNPX $149.50
  • Technical
  • Relative Strength Index (RSI)
  • TNON 53.89
  • GNPX 81.74
  • Support Level
  • TNON $1.12
  • GNPX $7.71
  • Resistance Level
  • TNON $1.44
  • GNPX $11.34
  • Average True Range (ATR)
  • TNON 0.08
  • GNPX 0.84
  • MACD
  • TNON 0.00
  • GNPX 1.14
  • Stochastic Oscillator
  • TNON 45.71
  • GNPX 75.74

About TNON Tenon Medical Inc.

Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

Share on Social Networks: